P&K Skin Research Center Co., Ltd. (KOSDAQ:347740)

Market Cap	57.65B -8.0%
Revenue (ttm)	22.78B +25.2%
Net Income	4.69B -1.7%
EPS	162.00 -0.3%
Shares Out	28.88M
PE Ratio	12.32
Forward PE	n/a
Dividend	40.00 (1.93%)
Ex-Dividend Date	Dec 29, 2025

Volume	144,082
Average Volume	104,786
Open	2,080.00
Previous Close	2,070.00
Day's Range	1,996.00 - 2,090.00
52-Week Range	1,974.00 - 3,300.00
Beta	0.71
RSI	44.64
Earnings Date	Feb 27, 2026

About P&K Skin Research Center

P&K Skin Research Center Co., Ltd. engages in the evaluation and research of dermatological products in South Korea. It provides scientific information and technical support services for new cosmetic raw material development, functional cosmetics, and human application testing of quasi-drugs. The company performs human application, safety, efficacy, cosmeceuticals, health food, sensory, and in vitro tests. It also manufactures and sells raw pharmaceutical and cosmetic materials, and raw materials for health foods. The company was founded in 201...

• Industry: Commercial Physical and Biological Research
• Founded: 2010
• Employees: 99
• Stock Exchange: KOSDAQ
• Ticker Symbol: 347740

Financial Performance

In 2024, P&K Skin Research Center's revenue was 17.85 billion, an increase of 20.24% compared to the previous year's 14.84 billion. Earnings were 5.82 billion, an increase of 20.84%.